The intrarenal renin-angiotensin system in hypertension

Advances in Chronic Kidney Disease

Volumn 22, Issue 3, 2015, Pages 204-210

  Carey, Robert M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Angiotensin; Hypertension; Kidney; Renin; Sodium

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN III; ANGIOTENSIN[1-7]; MAS RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PRORENIN RECEPTOR; UNCLASSIFIED DRUG; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; SODIUM;

BLOOD PRESSURE REGULATION; HUMAN; HYPERTENSION; INTRARENAL RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; KIDNEY; METABOLISM;

ANGIOTENSIN I; ANGIOTENSIN II; HUMANS; HYPERTENSION; KIDNEY; PEPTIDYL-DIPEPTIDASE A; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; SODIUM;

EID: 84928007939     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2014.11.004     Document Type: Review

References (85)

1. James P.A., Oparil S., Carter B.L., et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC8). JAMA 2014, 311(5):507-520.
2. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of theJoint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 2003, 42(6):1206-1252.
3. Weber M.A., Schiffrin E.L., White W.B., et al. Clinical practice guidelines for the management of hypertension in the community. A statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens 2014, 16(1):14-26.
4. Funder J.W., Carey R.M., Fardella C., et al. Case detection, diagnosis and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008, 93(9):3266-3281.
5. Siragy H.M., Carey R.M. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 2003, 24(3):261-271.
6. Carey R.M. Cardiovascular and renal regulation by the angiotensin type-2 receptor: the AT2 receptor comes of age. Hypertension 2005, 45(5):840-844.
7. 2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther 2008, 120(3):292-316.
8. Siragy H.M., Xue C., Abadir P., Carey R.M. Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation. Hypertension 2005, 45(1):133-137.
9. Carey R.M. Newly discovered components and actions of the renin-angiotensin system. Hypertension 2013, 62(5):818-822.
10. Kimbrough H.M., Vaughan E.D., Carey R.M., Ayers C.R. Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circ Res 1977, 40(2):174-178.
11. Levens N.R., Freedlender A.E., Peach M.J., Carey R.M. Control of renalfunction by intrarenal angiotensin II. Endocrinology 1983, 112(1):43-49.
12. Levens N.R., Peach M.J., Carey R.M. Role of the intrarenal renin-angiotensin system in the control of renal function. Circ Res 1981, 48(2):157-167.
13. Navar L.G., Lewis L., Hymel A., Braam B., Mitchell K.D. Tubular fluidconcentrations and kidney contents of angiotensins I and II in anesthetized rats. J Am Soc Nephrol 1994, 5(4):1153-1158.
14. Siragy H.M., Howell N.L., Peach M.J., Carey R.M. Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion and renin inhibition. Hypertension 1995, 25(5):1021-1024.
15. Davisson R.L., Ding Y., Stee D.E., Caterall J.P., Sigmund C.D. Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice. Physiol Genomics 1999, 1(1):3-9.
16. Lavoie J.L., Lake-Bruse K.D., Sigmund C.D. Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the proximal tubule. Am J Physiol Renal Physiol 2004, 286(5):F965-F971.
17. Crowley S.D., Gurley S.B., Oliverio M.I., et al. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 2005, 115(4):1092-1099.
18. Crowley S.D., Gurley S.B., Herrera M.J., et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in thekidney. Proc Natl Acad Sci U S A 2006, 103(47):17985-17990.
19. Gurley S.B., Riquier-Brison A.D., Schnerman J., et al. AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab 2011, 13(4):469-475.
20. Li X.C., Cook J.L., Rubera I., Tauc M., Zhang F., Zhuo J.L. Intrarenal transfer of an intracellular cyan fluorescent fusion of angiotensin II selectively in proximal tubules increases blood pressure in rats and mice. Am J Physiol Renal Physiol 2011, 300(5):F1076-F1088.
21. Li X.C., Zhuo J.L. Proximal tubule-dominant transfer of AT1a receptors induces blood pressure responses to intracellular angiotensin II in AT1a receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol 2013, 304(8):R588-R598.
22. Navar L.G., Harrison-Bernard L.M., Nishiyama A., Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002, 39(8):316-322.
23. Navar L.G., Kobori H., Prieto-Carrasquero M. Intrarenal angiotensin II and hypertension. Curr Hypertens Rep 2003, 5(2):135-143.
24. Navar L.G. Translational studies on augmentation of intratubular renin-angiotensin system in hypertension. Kidney Int Suppl 2013, 3(4):321-325.
25. Trippodo N.C., Frohlich E.D. Similarities of genetic (spontaneous) hypertension: man and rat. Circ Res 1981, 48(3):309-319.
26. Biollaz J., Waeber B., Diezi J., Burnier M., Brunner H.R. Lithium infusion to study sodium handling in unanesthetized hypertensive rats. Hypertension 1986, 8(2):117-121.
27. Beierwaltes W.H., Arendshorst W.J., Klemmer P.J. Electrolyte and water balance in young spontaneously hypertensive rats. Hypertension 1982, 4(6):908-915.
28. Guyton A.C., Coleman T.G., Young D.B., Lohmeier T.E., DeClue J.W. Salt balance and long-term blood pressure control. Annu Rev Med 1980, 31(2):15-27.
29. Arendshorst W.J., Beierwaltes W.H. Renal tubular reabsorption in spontaneously hypertensive rats. Am J Physiol Renal Physiol 1979, 237(1):F38-F47.
30. Omvik P., Tarazi R.C., Brave E.L. Regulation of sodium balance in hypertension. Hypertension 1908, 2(4):515-523.
31. Meng Q.C., Durand J., Chen Y.-F., Oparil S. Effects of dietary salt onangiotensin peptides in the kidney. J Am Soc Nephrol 1995, 6(4):1209-1215.
32. Cheng H.-F., Wang J.-L., Vinson G.P., Harris R.C. Young SHR express increased type 1 angiotensin II receptors in renal proximal tubule. Am J Physiol Renal Physiol 1998, 274(1 pt 2):F10-F17.
33. Yoneda M., Sanada H., Yatabe J., et al. Differential effects of angiotensin II type 1 receptor antisense oligonucleotides on renal function in spontaneously hypertensive rats. Hypertension 2005, 46(1):58-65.
34. Kobori H., Ozawa Y., Suzuke Y., Nishiyama A. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol 2005, 16(7):2073-2080.
35. Landgraf S.S., Wengert M., Silva J.S., et al. Changes in angiotensin receptor expression play a pivotal role in the renal damage observed in spontaneously hypertensive rats. Am J Physiol Renal Physiol 2011, 300(2):F499-F510.
36. Lee H.-A., Cho H.-M., Lee D.-Y., Kim K.-C., Han H.S., Kim I.K. Tissue-specific upregulation of angiotensin converting enzyme 1 in spontaneously hypertensive rats through histone code modifications. Hypertension 2012, 59(3):621-626.
37. Kobori H., Harrison-Bernard L.M., Navar L.G. Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension 2001, 37(5):1329-1335.
38. Kobori H., Nangaku M., Navar L.G., Nishiyama A. The intrarenal renin-angiotensin system: from physiology to pathobiology of hypertension and kidney disease. Pharmacol Rev 2007, 59(3):251-287.
39. Navar L.G., Kobori H., Prieto M.C., Gonzalez-Villalobos R.A. Intratubular renin-angiotensin system in hypertension. Hypertension 2011, 57(3):355-362.
40. 1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependenthypertensive rats. Am J Physiol Renal Physiol 2005, 289(3):F632-F637.
41. Prieto-Carrasquero M.C., Williams D.E., Liu L., Kavanaugh K.I., Mullins J.J., Mitchell K.D. Enhancement of renin and prorenin receptor in collecting duct of Cyp1a1-Ren 2 rats may contribute to development and progression of malignant hypertension. Am J Physiol Renl Physiol 2011, 300(2):F581-F588.
42. 1 receptor. Hypertension 2002, 39(1):116-121.
43. Zou L.X., Hymel A., Imig J.D., Navar L.G. Renal accumulation of circulating angiotensin II in angiotensin II-infused rats. Hypertension 1996, 27(3 pt 2):658-662.
44. 1 receptor. Am J Hypertens 1998, 11(5):570-578.
45. 1a receptor-deficient mice. Am J Physiol Renal Physiol 2007, 293(2):F586-F593.
46. Matsusaka T., Niimura F., Shimizu A., et al. Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol 2012, 23(7):1181-1189.
47. Matsusaka R., Niimura F., Pastan I., Shintani A., Nishiyama A., Ichikawa I. Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation. Kidney Int 2014, 85(5):1068-1077.
48. Abadir P.M., Walston J.D., Carey R.M. Subcellular characteristics of functional intracellular renin-angiotenisn systems. Peptides 2012, 38(2):437-445.
49. Gwathmey T.M., Alzayadneh E.M., Pendergrass K.D., Chappell M.C. Novel roles of nuclear angiotensin receptors and signaling mechanisms. Am J Physiol Regul Integr Comp Physiol 2012, 302(5):R518-R530.
50. Abadir P.M., Foster D.B., Crow M., et al. Identification and characterization of a functional mitochondrial angiotensin system. Proc Natl Acad Sci U S A 2011, 108(36):14849-14854.
51. Li X.C., Zhuo J.L. Proximal tubule-dominant transfer of AT(1a) receptors induces blood pressure responses to intracellular angiotensin II in AT(1a) receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol 2013, 304(8):R588-598.
52. Miyata N., Park F., Li X.F., Cowley A.W. Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am J Physiol 1999, 277(3 pt 2):F437-F446.
53. 2 receptor stimulation on vascular biology, kidney function and blood pressure. Integr Blood Press Control 2013, 6(6):153-161.
54. 2 receptors: beneficial counter-regulatory role in natriuresis: intrarenal mechanisms and therapeutic potential. Pflugers Arch 2013, 120(1):476-479.
55. 2 receptors in natriuresis: intrarenal mechanisms and therapeutic potential. Clin Exp Pharmacol Physiol 2013, 40(8):527-534.
56. Carey R.M. The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressure. Hypertension 2013, 61(3):673-680.
57. 2 receptor-nediated natriuresis in rats. Hypertension 2008, 51(2):460-465.
58. Kemp B.A., Bell J.F., Rottkamp D.M., et al. Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type-2 receptors. Hypertension 2012, 60(2):387-395.
59. 2 receptor selectivity and vascular function. Hypertension 2011, 57(3):570-576.
60. 2 receptors. Clin Sci 2011, 121(7):297-303.
61. 2 receptor activation induces natriuresis and lowers blood pressure. Circ Res 2014, 115(3):388-399.
62. Chappell M.C. Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin (1-7)-MAS receptor axis: more than regulation of blood pressure. Hypertension 2007, 50(4):596-599.
63. Ferrario C.M. Angiotensin-converting enzyme 2 and angiotensin (1-7): an evolving story in cardiovascular regulation. Hypertension 2006, 47(3):515-521.
64. Vickers C., Hales P., Kaushik V., et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002, 277(17):14838-14843.
65. Santos R.A., Simoes E., Silva A.C., et al. Angiotensin (1-7) is an endogenous ligand for the G protein-coupled receptor MAS. Proc Natl Acad Sci U S A 2003, 100(14):8258-8263.
66. Ferrario C.M., Varagic J. The Ang-(1-7)/ACE-2/Mas axis in the regulation of nephron function. Am J Physiol Renal Physiol 2010, 298(6):F1297-F1305.
67. Chappell M.C. Nonclassical renin-angiotensin system and renal function. Compr Physiol 2012, 2(4):2733-2752.
68. Shaltout H.A., Westwood B.M., Averill D.B., et al. Angiotensin metabolism in renal proximal tubules, urine and serum of sheep: evidence for ACE 2-dependent processing of angiotensin II. Am J Physiol Renal Physiol 2007, 292(1):F82-F91.
69. O'Neill J., Corbett A., Johns E.J. Dietary sodium intake modulates renal excretory responses to intrarenal angiotensin (1-7) administration in anesthetized rats. Am J Physiol Regul Integr Comp Physiol 2013, 304(3):R260-R266.
70. Ferrario C.M., Chappell M.C., Tallant E.A., Brosnihan K.B., Diz D.I. Counterregulatory actions of angiotensin (1-7). Hypertension 1997, 30(3 Pt 2):535-541.
71. +-ATPase activity through AT2 receptor. Regul Pept 2004, 120(1-3):167-175.
72. +-ATPase by Ang (1-7). Biochem J 2006, 395(1):183-190.
73. Castelo-Branco R.C., Leite-Delova D.C., deMello-Aires M. Dose-dependent effects of angiotensin (1-7) on the NHE3 exchanger and [Ca(2+0](i) in invivo proximal tubules. Am J Physiol Renal Physiol 2013, 304(10):F1258-F1265.
74. Botelho-Santos G.A., Sampaio W.O., Reudelhuber T.L., Bader M., Campagnole-Santos M.R., Santos R.A. Exression of an amgoptmesom-(1-7)-producing fusion protein in rats induced marked changes in regional vascular resistance. Am J Physiol Heart Circ Physiol 2007, 292(5):H2485-H2490.
75. Santos R.A., Ferreira A.J., Nadu A.P., et al. Expression of an angiotensin-(1-7) fusion protein produces cardioprotective effects in rats. Physiol Genomics 2004, 17(3):292-299.
76. Botelho-Santos G.A., Bader M., Alenina N., Santos R.A. Altered regional blood flow distribution in Mas-deficient mice. Ther Adv Cardiovasc Dis 2013, 6(5):201-211.
77. Walther T., Wessel N., Kang N., et al. Altered heart rate and blood pressure variability in mice lacking the Mas protooncogene. Braz J Med Biol Res 2000, 33(1):1-9.
78. Heringer-Walther S., Gembardt R., Perschel F.H., Katz N., Schulthsiss H.P., Walther T. The genetic deletion of Mas abolishes salt induced hypertension in mice. Eur J Pharmacol 2012, 689(1-3):147-153.
79. Nguyen F., Delarue R., Burckle C., Bouzhir L., Giller T., Sraer J.D. Pivotalrole of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002, 109(11):1417-1427.
80. Nguyen G., Delarue F., Berrou J., Rondeau E., Sraer J.D. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int 1996, 50(6):1897-1903.
81. Advani A., Kelly D.J., Cox A.J., et al. The (Pro) renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidney. Hypertension 2009, 54(2):261-269.
82. Huang Y., Novle N.A., Zhang J., Xu C., Border W.A. Renin-stimulated TGF-beta 1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int 2007, 72(1):45-52.
83. Zhang J., Wu J., Gu C., Noble N.A., Border W.A., Huang Y. Receptor-mediated nonproteolytic activation of prorenin and induction of TGF-β1 and PAI-1 expression in renal mesangial cells. Am J Physiol Renal Physiol 2012, 303(1):F11-F20.
84. Lautner R.Q., Villela D.C., Fraga-Silva R.A., et al. Discovery and characterization of alamandine: a novel component of the renin-angiotensin system. Circ Res 2013, 112(8):1104-1111.
85. Gambardt F., Grajewske S., Vahl M., Schultheiss H.P., Walther R. Angiotensin metabolites can stimulate receptors of the Mas-related genes family. Mol Cell Biochem 2008, 319(1-2):115-123.